Kou, Wenjun
Pandolfino, John E.
Kahrilas, Peter J.
Patankar, Neelesh A.
Funding for this research was provided by:
U.S. Public Health Service (R01 DK079902, R01 DK056033)
Article History
Received: 21 December 2017
Accepted: 20 March 2018
First Online: 11 April 2018
Compliance with ethical standards
:
: John E. Pandolfino discloses consulting and educational association with Medtronic, Sandhill Scientific and Ironwood Pharmaceuticals, and stock options with Crospon. Wenjun Kou, Peter J. Kahrilas, and Neelesh A. Patankar declare that they have no conflict of interest.
: This work was supported by Public Health Service grants DK079902 (to J.E.P.) and DK056033 (to P.J.K).